Rare diseases
Investigational molecules
Locations
Study on ANV600 and Pembrolizumab for Patients with Advanced Solid Tumors
BelgiumStudy of Debio 4228 for Patients with Advanced or Metastatic Prostate Cancer
BelgiumStudy on the Safety of ARV-471 and Everolimus for Patients with Advanced or Metastatic ER+, HER2- Breast Cancer
SpainStudy of Resmetirom in Patients with Well-compensated Non-alcoholic Steatohepatitis (NASH) Cirrhosis to Evaluate Effects on Liver Health
BelgiumStudy Comparing Zimberelimab and Domvanalimab with Chemotherapy to Pembrolizumab with Chemotherapy for Patients with Untreated Metastatic Non-Small Cell Lung Cancer
AustriaStudy on Tolebrutinib for Patients with Primary Progressive Multiple Sclerosis
AustriaStudy of secukinumab and prednisone combination therapy for patients with giant cell arteritis (GCA): Evaluation of treatment effectiveness and safety
AustriaStudy on Palbociclib and Endocrine Therapy for Patients with HR+/HER2- Early Breast Cancer
AustriaStudy of Pembrolizumab for Patients with Relapsed or Refractory Classical Hodgkin's Lymphoma or Primary Mediastinal Large B-cell Lymphoma
CzechiaStudy on Acalabrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients Without del(17p) or TP53 Mutation
AustriaStudy on Pausing Treatment with Pembrolizumab and Axitinib in Patients with Metastatic Kidney Cancer at Good or Intermediate Risk
FranceStudy on the Effectiveness and Safety of Atropine and DIMS Lenses for Myopia Control in Children
SpainTell us about your condition – we search every trial in Europe and connect you with the right site.
